A detailed history of Pier Capital, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Pier Capital, LLC holds 82,480 shares of IMCR stock, worth $2.33 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
82,480
Previous 81,306 1.44%
Holding current value
$2.33 Million
Previous $2.76 Million 6.82%
% of portfolio
0.38%
Previous 0.43%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$30.06 - $41.49 $35,290 - $48,709
1,174 Added 1.44%
82,480 $2.57 Million
Q2 2024

Aug 07, 2024

SELL
$33.78 - $63.75 $227,947 - $430,185
-6,748 Reduced 7.66%
81,306 $2.76 Million
Q1 2024

May 02, 2024

BUY
$60.14 - $75.36 $111,379 - $139,566
1,852 Added 2.15%
88,054 $5.72 Million
Q4 2023

Feb 15, 2024

SELL
$42.85 - $69.5 $52,277 - $84,790
-1,220 Reduced 1.4%
86,202 $5.89 Million
Q3 2023

Nov 14, 2023

BUY
$49.5 - $66.6 $947,182 - $1.27 Million
19,135 Added 28.02%
87,422 $4.54 Million
Q2 2023

Aug 14, 2023

SELL
$48.54 - $61.64 $12,474 - $15,841
-257 Reduced 0.37%
68,287 $4.09 Million
Q1 2023

May 10, 2023

SELL
$46.12 - $65.71 $8,716 - $12,419
-189 Reduced 0.27%
68,544 $3.39 Million
Q4 2022

Feb 15, 2023

SELL
$45.51 - $65.08 $44,281 - $63,322
-973 Reduced 1.4%
68,733 $3.92 Million
Q3 2022

Nov 15, 2022

SELL
$37.34 - $57.44 $2 Million - $3.08 Million
-53,688 Reduced 43.51%
69,706 $3.27 Million
Q2 2022

Aug 15, 2022

SELL
$25.46 - $37.72 $2.88 Million - $4.27 Million
-113,222 Reduced 47.85%
123,394 $4.6 Million
Q1 2022

May 10, 2022

SELL
$18.94 - $34.29 $21,970 - $39,776
-1,160 Reduced 0.49%
236,616 $7.08 Million
Q4 2021

Feb 10, 2022

BUY
$27.58 - $40.0 $4.39 Million - $6.37 Million
159,262 Added 202.85%
237,776 $8.14 Million
Q3 2021

Nov 10, 2021

BUY
$27.98 - $40.0 $2.2 Million - $3.14 Million
78,514 New
78,514 $2.91 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.